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Objective
Dedicated radionuclide imaging of the spleen
in useful in conditions such as accessory
spleen and splenic trauma. Nuclear
Medicine plays a key role in the diagnostic
molecular SPECT/CT imaging of splenic
disorders.

Methods
The patient was injected with 10.0 mCi (370 MBq) of
heat-denatured, Tc-99m–labeled autologous RBCs
(HDRBC). The tracer is prepared by labeling RBCs
removed from the patient with Tc-99m in vitro. The
labeled RBCs are damaged by heating them in a
water bath at 49° C for 20 minutes.
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T2 MRI image of abdomen

Results
53 year-old male with a history of diverticulitis,
presented with abdomen pain. He was sent for CT
of the abdomen w/IV contrast that showed trace
periappendiceal fat. He was then referred for MRI
of the abdomen, which showed a well-defined
lesion within the pancreatic tail measuring
approximately
1.3 x 1.7 cm, suspicious for a pancreatic
neuroendocrine tumor versus accessory spleen. A
nuclear medicine SPECT/CT scan was
recommended to rule out the possibility that this
lesion represent splenic tissue.
SPECT/CT images of the abdomen demonstrate
focal tracer activity, approximately 1.7 cm in the
pancreatic tail, corresponding to the finding noted
on the recent MRI scan. This SPECT/CT finding is
consistent with a splenule in the pancreatic tail.

Figure 3
SPECT/CT coronal abdomen image

Figure 4
SPECT/CT axial abdomen image

Conclusion
SPECT/CT Imaging combine with HDRBC Tc-99m–labeled autologous RBCs scintigraphy is an underused
modality that is highly specific for detecting splenic trauma or accessory splenic tissue. This imaging
procedure would eliminate the need for further invasive procedures including tissue sampling.

